BÜHLMANN Calprotectin Test Introduced In Belgium

The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation provided data for the excellent technical quality of the assay as well as the high sensitivity of our monoclonal assay for the patients tested. The data of the evaluation also resulted in a presentation at the annual meeting of the Belgian Society For Clinical Biology.